MASSACHUSETTS FINANCIAL SERVICES CO /MA/
Position in IMCR — Immunocore Holdings plc
CIK 912938
Boston, MA
Position in IMCR
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$12,282,295
-$1,858,697 QoQ
Shares Held
407,373
-0.0% QoQ
Ownership
0.801%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in IMCR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MASSACHUSETTS FINANCIAL SERVICES CO /MA/ holds $1,374,765,738 across 53 Biotechnology names. IMCR ranks #15 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
1,860,669 | $425,590,816 | |
| 2 | TECH |
BIO-TECHNE Corp
|
3,733,248 | $195,099,537 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
496,004 | $164,112,841 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
327,498 | $146,240,953 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
411,543 | $82,164,559 | |
| 6 | BNTX |
BioNTech SE
|
670,514 | $59,595,283 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
666,116 | $50,018,650 | |
| 8 | INCY |
Incyte Corp
|
410,729 | $38,657,809 |
All Filings in IMCR
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,282,295 | 407,373 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $14,140,992 | 407,404 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $16,072,319 | 442,398 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $13,988,168 | 445,767 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $13,670,482 | 460,751 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $13,541,827 | 459,045 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $15,509,619 | 498,221 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $13,236,247 | 390,565 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $20,222,865 | 311,121 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $21,357,378 | 312,608 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $16,210,809 | 312,347 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $21,703,301 | 361,963 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $18,074,374 | 365,582 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $20,883,853 | 365,934 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $17,120,801 | 364,738 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $12,683,236 | 339,942 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $10,240,092 | 342,478 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $11,404,659 | 333,080 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $12,437,429 | 335,512 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $3,796,675 | 97,226 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $4,150,660 | 97,502 | Shares | Sole | 2021-05-13 | |
| No filing history on record for this holder in this stock. | ||||||